US FDA approves first postpartum depression pill


WASHINGTON — Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the United States each year. The Food and Drug Administration on Friday granted approval for the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. […]

The post US FDA approves first postpartum depression pill appeared first on Inquirer News.

Read more at : inquirer

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.